Alnylam Pharmaceuticals total liabilities and share holders equity for the quarter ending September 30, 2024 was $4.205B, a 9.53% increase year-over-year.
Alnylam Pharmaceuticals total liabilities and share holders equity for 2023 was $3.83B, a 7.99% increase from 2022.
Alnylam Pharmaceuticals total liabilities and share holders equity for 2022 was $3.546B, a 2.66% decline from 2021.
Alnylam Pharmaceuticals total liabilities and share holders equity for 2021 was $3.643B, a 6.93% increase from 2020.
Alnylam Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | ALNY